These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2550424)
1. Characterization of the binding of human tissue-type plasminogen activator to platelets. Vaughan DE; Mendelsohn ME; Declerck PJ; Van Houtte E; Collen D; Loscalzo J J Biol Chem; 1989 Sep; 264(27):15869-74. PubMed ID: 2550424 [TBL] [Abstract][Full Text] [Related]
2. Evidence for a novel binding protein to urokinase-type plasminogen activator in platelet membranes. Jiang Y; Pannell R; Liu JN; Gurewich V Blood; 1996 Apr; 87(7):2775-81. PubMed ID: 8639894 [TBL] [Abstract][Full Text] [Related]
3. Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface. Braaten JV; Jerome WG; Hantgan RR Blood; 1994 Feb; 83(4):982-93. PubMed ID: 8111066 [TBL] [Abstract][Full Text] [Related]
4. Binding and activation of plasminogen on the platelet surface. Miles LA; Plow EF J Biol Chem; 1985 Apr; 260(7):4303-11. PubMed ID: 3920216 [TBL] [Abstract][Full Text] [Related]
5. Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens. Reuning U; Bang NU Arterioscler Thromb; 1992 Oct; 12(10):1161-70. PubMed ID: 1327097 [TBL] [Abstract][Full Text] [Related]
6. Lipoprotein(a) binds to human platelets and attenuates plasminogen binding and activation. Ezratty A; Simon DI; Loscalzo J Biochemistry; 1993 May; 32(17):4628-33. PubMed ID: 8485140 [TBL] [Abstract][Full Text] [Related]
7. Identification and partial characterization by chemical cross-linking of a binding protein for tissue-type plasminogen activator (t-PA) on rat hepatoma cells. A plasminogen activator inhibitor type 1-independent t-PA receptor. Bu G; Morton PA; Schwartz AL J Biol Chem; 1992 Aug; 267(22):15595-602. PubMed ID: 1322401 [TBL] [Abstract][Full Text] [Related]
8. Thrombin decreases the urokinase receptor and surface-localized fibrinolysis in cultured endothelial cells. Li XN; Varma VK; Parks JM; Benza RL; Koons JC; Grammer JR; Grenett H; Tabengwa EM; Booyse FM Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):410-9. PubMed ID: 7749851 [TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase. Hajjar KA; Hamel NM J Biol Chem; 1990 Feb; 265(5):2908-16. PubMed ID: 2154465 [TBL] [Abstract][Full Text] [Related]
10. Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells. Barnathan ES; Kuo A; Rosenfeld L; Karikó K; Leski M; Robbiati F; Nolli ML; Henkin J; Cines DB J Biol Chem; 1990 Feb; 265(5):2865-72. PubMed ID: 2154462 [TBL] [Abstract][Full Text] [Related]
11. Specific binding of blood coagulation factor XIIIa to thrombin-stimulated platelets. Greenberg CS; Shuman MA J Biol Chem; 1984 Dec; 259(23):14721-7. PubMed ID: 6150044 [TBL] [Abstract][Full Text] [Related]
12. Characterization of a fusion protein consisting of amino acids 1 to 263 of tissue-type plasminogen activator and amino acids 144 to 411 of urokinase-type plasminogen activator. Nelles L; Lijnen HR; Collen D; Holmes WE J Biol Chem; 1987 Aug; 262(22):10855-62. PubMed ID: 2956260 [TBL] [Abstract][Full Text] [Related]
13. Kinetics and mechanism of platelet-surface plasminogen activation by tissue-type plasminogen activator. Ouimet H; Freedman JE; Loscalzo J Biochemistry; 1994 Mar; 33(10):2970-6. PubMed ID: 8130211 [TBL] [Abstract][Full Text] [Related]
15. Biochemical and functional characterization of human tissue-type plasminogen activator variants with mutagenized kringle domains. Collen D; Lijnen HR; Bulens F; Vandamme AM; Tulinsky A; Nelles L J Biol Chem; 1990 Jul; 265(21):12184-91. PubMed ID: 2115513 [TBL] [Abstract][Full Text] [Related]
16. On the reversible interaction of plasminogen activator inhibitor-1 with tissue-type plasminogen activator and with urokinase-type plasminogen activator. Lijnen HR; Van Hoef B; Collen D J Biol Chem; 1991 Mar; 266(7):4041-4. PubMed ID: 1900284 [TBL] [Abstract][Full Text] [Related]
17. Reciprocating autocatalytic interactions between platelets and the activation system. Ouimet H; Loscalzo J Thromb Res; 1993 Jun; 70(5):355-64. PubMed ID: 8397449 [TBL] [Abstract][Full Text] [Related]
18. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells. Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828 [TBL] [Abstract][Full Text] [Related]
19. Thrombin stimulation of platelets induces plasminogen activation mediated by endogenous urokinase-type plasminogen activator. Lenich C; Liu JN; Gurewich V Blood; 1997 Nov; 90(9):3579-86. PubMed ID: 9345041 [TBL] [Abstract][Full Text] [Related]
20. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA. Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]